http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001520234-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08 |
| filingDate | 1998-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2001-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2001520234-A |
| titleOfInvention | Novel 3,6-hemiketals derived from 9a-azalides |
| abstract | (57) [Summary] The present invention provides the following general formula (I): Wherein R 1 is a hydroxyl group or the following formula (II): Wherein R 2 represents a hydrogen atom or a silyl group; R 3 represents a hydrogen atom or R 3 represents an ether group together with R 6 ; R 4 represents hydrogen; An atom, a (C 1 -C 4 ) acyl group or a group —COO— (CH 2 ) n —Ar (where n is 1 to 7 and Ar is an unsubstituted or substituted aryl group having a maximum of 18 carbon atoms) R 5 represents a hydrogen atom, a methyl group or a group —COO— (CH 2 ) n —Ar (where n is 1 to 7 and Ar is an unsubstituted or substituted having up to 18 carbon atoms) R 6 represents a hydroxyl group or represents an ether group together with R 3 ; R 7 represents a hydrogen atom, a (C 1 -C 12 ) alkyl group or a silyl group; R 8 and R 8 and a carbon atom at the C-11 / C-12 position together represent a cyclic carbonate; R 8 is a hydrogen atom, a (C 1 -C 12 ) alkyl group or A compound represented by the above general formula (I), which represents a silyl group or a cyclic carbonate ester together with R 7 and a carbon atom at the C-11 / C-12 position; It relates to pharmaceutically acceptable inorganic or organic acid addition salts, to a process for their preparation and to their use as antibiotics or as intermediates for the synthesis of other antibiotics. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7184520-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006513157-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007502857-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019127441-A |
| priorityDate | 1997-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 140.